Browsing: Expansion

Eli Lilly CEO Dave Ricks joins ‘Varney & Co.’ to discuss the Trump administration’s new Medicare GLP-1 Bridge Program, which will offer eligible seniors access to Lilly weight loss medications for $50 a month beginning July 1

This is a paid press release. Contact the press release distributor directly with any inquiries.

Immersive Fitness Brand to Open First Ohio Club in Powell, Featuring Eight Unique Themed Training Environments Designed to Transform the Gym Experience

STRONG Pilates, the global boutique fitness franchise combining Pilates with cardio and strength training, today announced its continued U.S. expansion with new studios opening across Boston, Charlotte, Los Angeles, Maryland, New York City and Philadelphia throughout 2026, alongside signed franchise agreements that will bring the brand to Miami, Florida; Portland, Oregon; and Charleston, South Carolina…

New York, United States, July 23, 2026 — Global intimate apparel brand AVIDLOVE today announced a strategic design expansion aligned with International Self-Care Day on July 24, reinforcing its foundational “Feel Every Spark” initiative. The release addresses a major cultural and macroeconomic pivot within the intimate apparel sector: the acceleration of consumer demand away from…

The Senate Veterans Affairs Committee is scheduled on July 22 to examine the future of the Department of Veterans Affairs (VA) research at a critical moment for veterans’ mental health treatment. Just nine days before the hearing, the Department of Veterans Affairs and the Department of Health and Human Services signed a Memorandum of Understanding…

Manny Pacquiao eyes expansion of boxing gym after opening flagship in LA HEADLINES: | HEADLINES: | Sports Manny Pacquiao eyes expansion of boxing gym after opening flagship in LA Paige JavierABS-CBN News Published July 14, 2026 03:20 PM PHT ADVERTISEMENT ADVERTISEMENT ADVERTISEMENT Read More: Boxing| Manny Pacquiao| Pacquiao Prime Boxing Gym| MP Promotions ABS-CBN Newsletter…

Vertex Pharmaceuticals has agreed to acquire Crinetics Pharmaceuticals for $10 billion cash, the companies said, in a deal that would expand the buyer’s rare disease portfolio beyond its anchor indication of cystic fibrosis (CF), by adding an approved treatment and a pipeline anchored by two Phase III candidates, all predicted to generate more than $5…